C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
530/13, 195/1.22
C12N 15/49 (2006.01) A61K 38/16 (2006.01) A61K 48/00 (2006.01) C07K 14/15 (2006.01) C07K 14/16 (2006.01) C12P 21/02 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2032158
Transdominant repressors of viral gene phenotypic expression derived from the rev gene product of HIV-1 or the rex gene product of HTLV-1 and corresponding mutated genes are described, having the capability of repressing the Rev function in HIV-1 and/or the Rex function in HTLV-I and HTLV-II. Transient gene expression analysis of a series of missense and deletion mutants has been used. Some of the mutants found repress both the Rev and the Rex function and are thus active in more than one viral species. Transdominant viral mutants represent a promising new class of anti-viral agents. Cellular expression of these transdominant inhibitors may be used in such therapeutic approaches as intracellular immunization in order to protect cells against the deleterious effects of viral, e.g. HIV-1 infection.
Bachmayer Helmut
Boehnlein Ernst
Cullen Bryan R.
Greene Warner C.
Hauber Joachim
Duke University
Kirby Eades Gale Baker
Novartis Ag
Sandoz Ltd.
LandOfFree
Multivalent repressor of gene function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multivalent repressor of gene function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multivalent repressor of gene function will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1552552